Allay Therapeutics
About Allay Therapeutics
Allay Therapeutics is pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation for patients and physicians. The company focuses on delivering weeks of localized pain management through innovative therapeutic technologies.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
| Round | Date | Amount | Investors |
|---|---|---|---|
| Series D | Jun 05, 2025 | $57.5M | Temasek Holdings, ClavystBio |
Founders
No founder information available.
Investors
ClavystBio
Corporate Venture Capital
Temasek Holdings
Corporate
Recent Mentions
New Raise 🏛️ Company: Allay Therapeutics 🔗 Website: https://t.co/Yd7F606Dxe 📊 Amount: $57.5 Million 🔄 Round: Series D 🧮 Valuation: N/A ⚙️ Industry: Biotechnology, Healthcare
Temasek-backed ClavystBio co-leads Allay Therapeutics' Series D https://t.co/6C6mwxlmN8
Temasek-backed ClavystBio co-leads Allay Therapeutics' Series D https://t.co/6C6mwxlmN8
Similar Startups
Alpheus Medical
85% matchA private, clinical-stage oncology company focused on developing innovative therapies for cancer tre...
Aortyx
85% matchA medtech scaleup focused on innovative bioresorbable patches designed to treat aortic diseases with...
CureBay
84% matchA hybrid healthcare platform focused on delivering last-mile medical services.
HAYA Therapeutics
84% matchHAYA Therapeutics is a precision medicines company focused on developing RNA-guided programmable the...